Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

FDA puts hold on clinical study of Vasomax

Aug. 12, 1999

BioSpecifics Technologies announces positive preliminary results in Peyronie's disease therapy

Aug. 11, 1999

Mochida presents potent and selective heterocyclic cGMP-PDE inhibitors

July 30, 1999

NS-49: preclinical pharmacokinetics of potential new agent for stress incontinence

July 28, 1999

Rochester Medical's female incontinence device receives CE mark

July 28, 1999

Nitrosylated alpha-adrenoceptor antagonists as potential agents for impotence

July 27, 1999

Alza expands promotion of Ditropan XL for overactive bladder

July 27, 1999

Z-350, a novel treatment for BPH with a dual mechanism of action

July 21, 1999

Potential new diuretic agents selected for detailed biological evaluation at Wakamoto

July 16, 1999

Recently issued patent covers Sanofi-Synthelabo's new M3 antagonists

July 16, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...